Literature DB >> 20551414

Acting on comparative effectiveness research in COPD.

Jerry A Krishnan, Richard A Mularski.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20551414     DOI: 10.1001/jama.2010.807

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  Comparative Effectiveness Research in Pediatric Respiratory Disease: Promise and Pitfalls.

Authors:  Kathleen J Ramos; Ranjani Somayaji; David P Nichols; Christopher H Goss
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

2.  A new taxonomy for stakeholder engagement in patient-centered outcomes research.

Authors:  Thomas W Concannon; Paul Meissner; Jo Anne Grunbaum; Newell McElwee; Jeanne-Marie Guise; John Santa; Patrick H Conway; Denise Daudelin; Elaine H Morrato; Laurel K Leslie
Journal:  J Gen Intern Med       Date:  2012-04-13       Impact factor: 5.128

3.  The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations.

Authors:  Brian D Stein; Adriana Bautista; Glen T Schumock; Todd A Lee; Jeffery T Charbeneau; Diane S Lauderdale; Edward T Naureckas; David O Meltzer; Jerry A Krishnan
Journal:  Chest       Date:  2011-07-14       Impact factor: 9.410

Review 4.  Comparative effectiveness research in chronic obstructive pulmonary disease.

Authors:  Richard A Mularski; Mary Ann McBurnie; Peter K Lindenauer; Todd A Lee; William M Vollmer; David H Au; Shannon S Carson; Jerry A Krishnan
Journal:  J Comp Eff Res       Date:  2012-01       Impact factor: 1.744

5.  Comparison of conventional medicine, TCM treatment, and combination of both conventional medicine and TCM treatment for patients with chronic obstructive pulmonary disease: study protocol of a randomized comparative effectiveness research trial.

Authors:  Jian-Sheng Li; Yang Xie; Su-Yun Li; Xue-Qing Yu
Journal:  Trials       Date:  2014-05-01       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.